We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biosensor Integrated in Active Microfluidic Cartridge Allows Superior Screening Possibilities

By LabMedica International staff writers
Posted on 06 Jan 2010
A polymer-based sensor integrated into an active microfluidic cartridge will allow simpler, faster, and systematic screening possibilities. More...
The new concept for diagnosis will permit, for example, doctors to diagnose a disease such as cancer, using only few microliters of blood taken from a patient.

The integration of sensing functionality as well as assay functionality into a compact fully-integrated cartridge-like device allowed transferring complexity from the macro to the micro system, leading to a Lab-on a-Chip. A polymer based technology platform was developed; it applies a label-free optical detection based on surface plasmon resonance (SPR).

Integrated into the cartridge the optical components (light source, waveguide, and detector) and fluidic elements for active liquid transport make it very suitable for diagnostics. The final product will be manufactured using large scale, mass production techniques resulting in a cartridge that will be inexpensive, disposable, and sensitive.

The polymer-based sensor the Plasmon enhanced SPR is being developed by the Surface Enhanced Micro Optical Fluidic Systems (SEMOFS) project (Chemnitz, Germany), supported by the European Commission with EUR 1.9 million in funding. The consortium of the project involves multidisciplinary expertise split among eight partners from five European countries, Switzerland, Belgium, Germany, France, and the UK.

SEMOFS was finished in February 2009, and tangible achievements have been reached. The hardware components of the integrated approach are technically operable. The cost estimations show that the cost target of less than EUR 50 is within reach. The concept is considered as being feasible for the new integrated biosensor approach. Some of the aspects targeted in the project need to be studied in more detail; these include the integration of all components into a single device to allow for example, clinical testing for cancer.

In order to begin utilizing project results it will be necessary to apply the components in several different applications, such as: excitation, microfluidic, polymer photodiode array for the low cost spectrometer, fast optimization in plasmonic devices design, and surface coating.

Related Links:
SEMOFS



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Collection and Transport System
PurSafe Plus®
Clinical Chemistry System
P780
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.